Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Igor Age Kos"'
Autor:
Igor Age Kos, Faissal Nemer Hajar, Gustavo Sarot Pereira da Cunha, Claudia Corte, Luisa Augusto Furlan, André Santa Maria, Douglas Valverde, Bárbara Emoingt Furtado, Miguel Morita Fernandes-Silva, Valderilio Feijó Azevedo
Publikováno v:
Vaccines, Vol 12, Iss 6, p 581 (2024)
Objective: Brazil was strongly affected by the COVID-19 pandemic. Its continental dimension and socio-demographic characteristics pose challenges to distribution and accessibility, making vaccination programs challenging. The objectives of the study
Externí odkaz:
https://doaj.org/article/f64611ae69684a90adda07ca0b5dc08e
Autor:
Lorenz Thurner, Natalie Fadle, Evi Regitz, Sophie Roth, Onur Cetin, Igor Age Kos, Simon Mauro Hess, Julia Bein, Rainer Maria Bohle, Martine Vornanen, Christer Sundström, Laurence de Leval, Enrico Tiacci, Peter Borchmann, Andreas Engert, Viola Poeschel, Gerhard Held, Eva C. Schwarz, Frank Neumann, Klaus-Dieter Preuss, Markus Hoth, Ralf Küppers, Karola Lehman, Martin-Leo Hansmann, Sören L. Becker, Moritz Bewarder, Sylvia Hartmann
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and
Externí odkaz:
https://doaj.org/article/5d85a252c48a4566b48ecb1ca09a4eef
Autor:
Moritz Bewarder, Dominic Kaddu-Mulindwa, Igor Age Kos, Vadim Lesan, Gerhard Held, Viola Poeschel, Lorenz Thurner, Joerg Thomas Bittenbring, Norbert Schmitz, Lorenz Truemper, Michael Pfreundschuh, Konstantinos Christofyllakis, Markus Loeffler, Bettina Altmann, Marita Ziepert
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/b5236005901343f7a19b7964ade12e91
Autor:
Lorenz Thurner, Natalie Fadle, Evi Regitz, Klaus-Dieter Preuss, Frank Neumann, Onur Cetin, Claudia Schormann, Marie-Christin Hoffmann, Christian Herr, Parastoo Kheiroddin, Torben Millard Rixecker, Robert Bals, Sylviane Muller, Bernhard Thurner, Christoph Kessel, Michael Kabesch, Moritz Bewarder, Kristina Heyne, Christian Lensch, Igor Age Kos
Publikováno v:
Journal of Translational Autoimmunity, Vol 5, Iss , Pp 100171- (2022)
Long COVID is a collection of symptoms as a late sequelae of SARS-CoV-2 infection. It often includes mental symptoms such as cognitive symptoms, persisting loss of smell and taste, in addition to exertional dyspnea. A role of various autoantibodies (
Externí odkaz:
https://doaj.org/article/345009a341144122b1a26a056a890e1e
Autor:
Valderilio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas-Santos, Geraldo da Rocha Castelar Pinheiro, Eduardo dos Santos Paiva
Publikováno v:
Advances in Rheumatology, Vol 59, Iss 1, Pp 1-5 (2019)
Abstract Background Benzbromarone is a uricosuric drug that has been used in the treatment of gout over the last 30 years. Due to its potent inhibition of the dominant apical (luminal) urate exchanger in the human proximal tubule URAT1, it reduces th
Externí odkaz:
https://doaj.org/article/94fd15f0157c423e83f50565896819fb
Publikováno v:
Drugs in Context, Vol 7, Pp 1-13 (2018)
Biosimilar products are already approved and marketed in several countries. The Food and Drug Administration has approved ten different biosimilars, and the European Medicines Agency has approved 40. Even though this scenario has provided important e
Externí odkaz:
https://doaj.org/article/fd50ebf373ee442e91133cc02b13d95c
Autor:
Igor Age Kos, Lorenz Thurner, Joerg Thomas Bittenbring, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa
Publikováno v:
Diagnostics, Vol 11, Iss 12, p 2174 (2021)
Lymphomas encompass a diverse group of malignant lymphoid neoplasms. Over recent years much scientific effort has been undertaken to identify and understand molecular changes in lymphomas, resulting in a wide range of genetic alterations that have be
Externí odkaz:
https://doaj.org/article/f7a6e7264bf84d6087d11bf64904eb1f
Autor:
Morton Aaron Scheinberg, Paulo Antonio Oldani Felix, Igor Age Kos, Maurício De Angelo Andrade, Valderilio Feijó Azevedo
Publikováno v:
Einstein (São Paulo), Vol 16, Iss 3
ABSTRACT The manufacturing process for biological products is complex, expensive and critical to the final product, with an impact on their efficacy and safety. They have been increasingly used to treat several diseases, and account for approximately
Externí odkaz:
https://doaj.org/article/18433db9d7074770b4239dd425a12ca0
Autor:
Jochen Pfeifer, Bernhard Thurner, Christoph Kessel, Natalie Fadle, Parastoo Kheiroddin, Evi Regitz, Marie-Christin Hoffmann, Igor Age Kos, Klaus-Dieter Preuss, Yvan Fischer, Klaus Roemer, Stefan Lohse, Kristina Heyne, Marie-Claire Detemple, Michael Fedlmeier, Hendrik Juenger, Harald Sauer, Sascha Meyer, Tilman Rohrer, Helmut Wittkowski, Sören L Becker, Katja Masjosthusmann, Robert Bals, Stephan Gerling, Sigrun Smola, Moritz Bewarder, Einat Birk, Andre Keren, Michael Böhm, André Jakob, Hashim Abdul-Khaliq, Jordi Anton, Michael Kabesch, Rosa Maria Pino-Ramirez, Dirk Foell, Lorenz Thurner
Publikováno v:
Lancet Rheumatology, The
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious complication of infection with SARS-CoV-2. A possible involvement of pathogenetically relevant autoantibodies has been discussed. Recently, neutralising autoantib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77f5fad11245b8ca744689a483886130
https://doi.org/10.1016/s2665-9913(22)00064-9
https://doi.org/10.1016/s2665-9913(22)00064-9
Autor:
Igor Age Kos, Maximilian Kiefer, Katharina Brill, Onur Cetin, Joerg Thomas Bittenbring, Manfred Ahlgrimm, Sigrun Smola, Stefan Lohse, Konstantinos Christofyllakis, Dominic Kaddu-Mulindwa, Frank Neumann, Moritz Bewarder, Lorenz Thurner
Publikováno v:
Expert review of vaccines. 21(11)
Patients with cancer and autoimmune diseases are at higher risk of severe COVID-19. They may not develop protective immune responses following vaccination. We investigated patients' cellular and humoral immune response after two COVID-19 vaccine dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf5bad3f40f28a02ddc59b75fa5cb85
https://pubmed.ncbi.nlm.nih.gov/35994606
https://pubmed.ncbi.nlm.nih.gov/35994606